View

The Study

Abstract 2796: Colibactin mutation signatures are associated with younger age of onset in colorectal cancer

In simple terms

This study found that kids and young adults with a certain kind of DNA damage in their colon cancer were more likely to get sick younger than older people. But it doesn't prove the bacteria caused the damage — maybe the cancer made the environment better for the bacteria, or something else caused both.

44%

Analysis score

44/ 44

Maximum 44 for a cross-sectional study.

Where the score came from

Reporting0
Methodology44
Publication100
Statistical54
Study type (basis of the score)
Cross-Sectional Study
Level 4 - Case series
What’s the bottom line?

Some E. coli bacteria in the gut make a poison called colibactin that damages DNA in colon cells, leaving a unique fingerprint of mutations.

Where does this study sit?

Reviews of RCTs (Meta-analyses)

Max 100

Randomized Trials

Max 90

Reviews of Cohort Studies

Max 85

Cohort Studies

Max 72

Reviews of Case-Control Studies

Max 63

Case-Control Studies

Max 58

Cross-Sectional & Case Series

Max 50

Expert Opinion

Max 5
StrongerWeaker
Cross-Sectional & Case Series
Level 4
44

44 / 100

Quality score

Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.

Cannot establish causation

Save studies & get personalized insights

Create a free account to save this study, track new evidence as it comes in, and get breakdowns of studies in the topics you care about.

Key takeaways

Summary

Based on the study abstract and findings.

  1. 1Yes — getting colon cancer 4 years earlier on average could mean more aggressive disease and less time for early detection.
  2. 2150 out of 1,884 colon cancer patients had this fingerprint; those patients were diagnosed at age 55 on average, compared to age 59 for others.

Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data

Publication

Journal

Cancer Research

Year

2024

Authors

Stefanie Gerstberger, M. Lumish, S. Hartner, Farheen Shah, Seongmin Choi, A. Luthra, Qingwen Jiang, H. J. Woo, Ahmed Mahmoud, H. Walch, Simran Asawa, M. Donoghue, A. Cercek, R. Yaeger, Andrew Mcpherson, F. Sánchez-Vega, K. Ganesh

Related Content

Claims (6)

Assertion

When human colon tissue grown in the lab is exposed to a specific type of E. coli that produces colibactin for three months, it develops a unique pattern of DNA damage that matches the pattern seen in human colorectal cancers.

Mechanistic
Read analysis
Assertion

Colorectal cancers with colibactin-related DNA damage patterns show the same levels of overall mutations and known cancer-causing gene changes as other colorectal cancers, suggesting colibactin causes cancer through a different biological mechanism.

Mechanistic
Read analysis
Assertion

Certain strains of E. coli that produce a toxin called colibactin are linked to a specific pattern of DNA damage found in colorectal tumors. This DNA damage pattern is more commonly found in tumors from people diagnosed with colorectal cancer before age 55 compared to those diagnosed at age 59 or older.

Correlational
Read analysis
Assertion

A specific pattern of DNA damage caused by a bacterial toxin can be identified in tumor samples using a targeted DNA sequencing test called MSK-IMPACT, without needing to sequence the entire genome.

Descriptive
Read analysis
Assertion

Certain strains of Escherichia coli that produce colibactin cause distinct double-strand breaks in the DNA of cells lining the colon, leading to characteristic mutation patterns known as SBS88 and ID18.

Mechanistic
Read analysis
Assertion

Colorectal cancers with a specific DNA damage pattern linked to colibactin-producing bacteria show more widespread changes in their genome compared to cancers without this pattern.

Correlational
Read analysis
Fit Body Science verdict — we translate health studies into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.